Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7324-7339
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Table 1 Patients and postoperative data
| Number of patients, n | 38 |
| Pancreatic ductal adenocarcinoma, n (%) | 38 (100) |
| Mean tumor dimension, cm | 3.2 1.1 (1.5-6.5) |
| Mean harvest lymph nodes, n | 34.2 15 (14-79) |
| Mean metastatic lymph nodes, n | 4.5 4.9 (1-23) |
| Angioinvasion, n (%) | 5 (13) |
| Perineural infiltration, n (%) | 33 (86.8) |
| T status, n (%) | |
| T1 | 2 (8.7) |
| T2 | 14 (60.9) |
| T3 | 7 (30.4) |
| T status, n (%) | |
| T1 | 3 (7.9) |
| T2 | 24 (63.2) |
| T3 | 11 (28.9) |
| N status, n (%) | |
| N0 | 7 (18.4) |
| N1 | 15 (39.5) |
| N2 | 16 (42.1) |
| Stage, n (%) | |
| I | 8 (21.1) |
| II | 14 (36.8) |
| III | 16 (42.1) |
| Patients with available follow-up, n | 24 |
| Patients with disease recurrence at 12 months, n (%) | 13 (54.1) |
| Patients treated with adjuvant CT, n (%) | 21 (87.5) |
| Recurrence during CT, n (%) | 11 (52.4) |
- Citation: Bianchini M, Giambelluca MA, Scavuzzo MC, Di Franco G, Guadagni S, Palmeri M, Furbetta N, Gianardi D, Funel N, Ricci C, Gaeta R, Pollina LE, Falcone A, Vivaldi C, Di Candio G, Biagioni F, Busceti CL, Morelli L, Fornai F. Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma. World J Gastroenterol 2021; 27(42): 7324-7339
- URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7324